Posts

Conference ‘New approaches for prioritisation and assessment of the risks of pharmaceuticals in the environment’

The two-day international conference ‘New approaches for prioritisation and assessment of the risks of pharmaceuticals in the environment’ will mark the end of the IMI-funded project ‘Intelligence-led assessment of pharmaceuticals in the environment’ (iPiE). The conference will take place on 24-25 June 2019 at the University of York (UK). It will provide an overview on […]

Presentation of the iPiE project at the SETAC Europe meeting

The project Intelligence-led assessment of pharmaceuticals in the environment (iPiE) will be presented at the SETAC Europe Annual Meeting in Helsinki, at a symposium organised by the SETAC Europe Pharmaceutical Interest Group. The symposium will take place on Sunday, 26 May 2019 (13:00 – 17:30). Its aim is to present the iPiE project in detail […]

Interview with Anja Coors in the current iPiE Newsletter

ECT is involved in the project ‘Intelligence-led assessment of pharmaceuticals in the environment’ (iPiE).  The iPiE project contributes to developing frameworks for intelligence-based environmental testing of pharmaceuticals and for prioritising legacy pharmaceuticals for targeted environmental risk assessment and environmental (bio-) monitoring. The current iPiE newsletter (Newsletter No 6) features an interview with Anja Coors, who […]

Intelligence-led Assessment of Pharmaceuticals in the Environment (iPiE)

Active pharmaceutical ingredients (APIs) of medicines for human use can be released to the environment during the manufacturing process, following use by patients or when unused medicines are disposed of in an incorrect manner. As APIs are biologically active compounds, concerns have been raised about the potential effects of APIs in the environment on human […]